JPS62246517A - 共同作用組成物 - Google Patents

共同作用組成物

Info

Publication number
JPS62246517A
JPS62246517A JP62034389A JP3438987A JPS62246517A JP S62246517 A JPS62246517 A JP S62246517A JP 62034389 A JP62034389 A JP 62034389A JP 3438987 A JP3438987 A JP 3438987A JP S62246517 A JPS62246517 A JP S62246517A
Authority
JP
Japan
Prior art keywords
compound
sulfadimidine
compounds
pyrimidine
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62034389A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0471890B2 (enExample
Inventor
ジョフレイ　ホワイト
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of JPS62246517A publication Critical patent/JPS62246517A/ja
Publication of JPH0471890B2 publication Critical patent/JPH0471890B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP62034389A 1986-02-18 1987-02-17 共同作用組成物 Granted JPS62246517A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8603962 1986-02-18
GB868603962A GB8603962D0 (en) 1986-02-18 1986-02-18 Chemical compositions

Publications (2)

Publication Number Publication Date
JPS62246517A true JPS62246517A (ja) 1987-10-27
JPH0471890B2 JPH0471890B2 (enExample) 1992-11-16

Family

ID=10593243

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62034389A Granted JPS62246517A (ja) 1986-02-18 1987-02-17 共同作用組成物

Country Status (10)

Country Link
EP (1) EP0238207B1 (enExample)
JP (1) JPS62246517A (enExample)
AT (1) ATE89732T1 (enExample)
AU (1) AU606330B2 (enExample)
CA (1) CA1285226C (enExample)
DE (1) DE3785953T2 (enExample)
ES (1) ES2055700T3 (enExample)
GB (1) GB8603962D0 (enExample)
NZ (1) NZ219298A (enExample)
ZA (1) ZA871140B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8903978D0 (en) * 1989-02-22 1989-04-05 Coopers Animal Health Chemical compositions
GB8915716D0 (en) * 1989-07-08 1989-08-31 Coopers Animal Health Pharmaceutical compositions
US5190760A (en) * 1989-07-08 1993-03-02 Coopers Animal Health Limited Solid pharmaceutical composition
GB9000241D0 (en) * 1990-01-05 1990-03-07 Coopers Animal Health Pharmaceutical use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use

Also Published As

Publication number Publication date
ES2055700T3 (es) 1994-09-01
DE3785953D1 (de) 1993-07-01
GB8603962D0 (en) 1986-03-26
JPH0471890B2 (enExample) 1992-11-16
CA1285226C (en) 1991-06-25
ZA871140B (en) 1988-09-28
ATE89732T1 (de) 1993-06-15
DE3785953T2 (de) 1993-09-30
AU6886887A (en) 1987-08-20
AU606330B2 (en) 1991-02-07
EP0238207B1 (en) 1993-05-26
EP0238207A1 (en) 1987-09-23
NZ219298A (en) 1990-06-26

Similar Documents

Publication Publication Date Title
CN102697784B (zh) 一种兽用恩诺沙星注射液及其制备方法
Utz et al. Amphotericin B toxicity: combined clinical staff conference at the National Institutes of Health
CN105853454A (zh) 一种广谱抗寄生虫药纳米乳剂及其制备方法
EP0655249B1 (de) Moenomycin als Arzneimittel zur Behandlung von Magengeschwüren
US6132715A (en) Method of inhibiting biosynthesis of tumor necrosis factor
DE69837007T2 (de) Verwendung von 9a-azaliden als antimikrobielle mittel für tiere
JPS62246517A (ja) 共同作用組成物
JPH072672A (ja) 抗菌性配合製剤
CN118452325A (zh) 一种组合物及其在抑菌和防治奶牛乳房炎中的应用
HUT63335A (en) Process for producing pharmaceutical compositions for treating diseases of mammals
RU2698820C1 (ru) Препарат для лечения мастита у коров в период лактации
BENNETT Review of selected aspects of pharmacology
CN110721152B (zh) 一种治疗动物皮肤寄生虫、真菌感染的缓释组合物
CZ290411B6 (cs) Farmaceutický prostředek
RU2103997C1 (ru) Лекарственное средство для лечения заболеваний животных микробной этиологии, способ лечения желудочно-кишечных заболеваний животных микробной этиологии и способы лечения гинекологических заболеваний коров микробной этиологии
AU621459B2 (en) Compositions comprising baquiloprim and sulphadimethoxine
JPS58134026A (ja) 抗菌組成物およびその製法と用途
RU2849173C1 (ru) Способ профилактики псевдомонозных гастроэнтеритов поросят
RU2384335C1 (ru) Препарат для лечения колибактериоза у молодняка сельскохозяйственных животных
KR20140082451A (ko) ＰＰＡＲδ 활성물질의 항생제, 화상 및 창상 치료제, 당뇨성 족부궤양 치료제로서의 용도
RU2258501C2 (ru) Способ применения этидия бромистого для лечения пироплазмоза лошадей
JP2002265354A (ja) 抗ピロリ菌剤組成物
Yamazaki STUDIES ON ANTIMICROBIAL SUBSTANCE B44P (STREPTOVARICIN) PRODUCED BY A STRAIN OF ACTINOMYCETES. III CHEMOTHERAPEUTIC EFFECT ON STAPHYLOCOCCAL INFECTION IN MICE
RU2228742C2 (ru) Способ лечения рецидивирующего иридоциклохориоидита лошадей
KR960015952B1 (ko) 동물의 하리치료제 조성물 및 이를 함유하는 제제

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term